Ronald B. Moss
Directeur/Bestuurslid bij Biosortia Pharmaceuticals, Inc.
Vermogen: 104 $ op 30-04-2024
Actieve functies van Ronald B. Moss
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Biosortia Pharmaceuticals, Inc.
Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH. | Directeur/Bestuurslid | - | - |
Loopbaan van Ronald B. Moss
Eerdere bekende functies van Ronald B. Moss
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DMK PHARMACEUTICALS CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-02-2017 | 14-10-2022 |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Algemeen Directeur | 01-10-2011 | 01-02-2017 |
Hoofd Techniek/Wetenschap/O&O | 01-01-2009 | 01-10-2011 | |
President | 01-10-2012 | 01-02-2017 | |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 01-06-2006 | 01-01-2009 |
Telos Pharmaceuticals LLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 | 01-03-2006 |
MERCK & CO., INC. | Algemeen Adviseur | 01-01-2003 | 01-01-2004 |
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Algemeen Directeur | 01-09-2002 | 01-01-2003 |
Hoofd Techniek/Wetenschap/O&O | 01-01-1994 | 01-09-2002 | |
President | 01-09-2002 | 01-01-2003 | |
Immunization Products Ltd. | Corporate Officer/Principal | 01-07-1993 | 01-01-1994 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Opleiding van Ronald B. Moss
Stony Brook University | Undergraduate Degree |
Chicago Medical School | Doctorate Degree |
Rosalind Franklin University of Medicine & Science | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 13 |
Operationeel
Chief Tech/Sci/R&D Officer | 5 |
Chief Executive Officer | 2 |
President | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 4 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
DMK PHARMACEUTICALS CORPORATION | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Telos Pharmaceuticals LLC | |
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
Immunization Products Ltd. | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Health Technology |
Biosortia Pharmaceuticals, Inc.
Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH. | Health Technology |
- Beurs
- Insiders
- Ronald B. Moss
- Ervaring